secwatch.observer — SEC 8-K summary
======================================

Issuer:     EyePoint, Inc. (EYPT)
CIK:        0001314102
Form:       8-K
Filed at:   2026-03-20T23:59:59+00:00
Accession:  0001193125-26-117745
Event type: litigation
Sentiment:  negative
Materiality: 0.60
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

EyePoint files defamation lawsuit against Ocular Therapeutix over false statements about DURAVYU
--------------------------------------------------------------------------------

- Complaint filed March 20, 2026 in Middlesex County Superior Court (Massachusetts).
- Alleges Ocular Therapeutix made false/misleading representations about EyePoint's lead product DURAVYU (vorolanib intravitreal insert).
- Claims include defamation, commercial disparagement, violation of Mass. Gen. L. c. 93A, and tortious interference.
- Seeks injunctive relief, public retraction, monetary damages, attorneys' fees, and other relief.
- EyePoint asserts defendant's actions harmed its business relations and clinical results reputation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314102/000119312526117745/0001193125-26-117745-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314102/000119312526117745/eypt-20260320.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-117745

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer